Cargando…
Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach
Atherosclerosis including its subclinical form is one of the key medical and social problems. At present, there is no therapy available for widespread use against subclinical atherosclerosis. The use of synthetic drugs for the prevention of arteriosclerosis in its early stages is not sufficient beca...
Autores principales: | Orekhov, Alexander N., Sobenin, Igor A., Revin, Victor V., Bobryshev, Yuri V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549547/ https://www.ncbi.nlm.nih.gov/pubmed/26347804 http://dx.doi.org/10.1155/2015/463797 |
Ejemplares similares
-
Mitochondrial Aging and Age-Related Dysfunction of Mitochondria
por: Chistiakov, Dimitry A., et al.
Publicado: (2014) -
Cell-Based Models for Development of Antiatherosclerotic Therapies
por: Zakiev, Emile R., et al.
Publicado: (2017) -
Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation
por: Chistiakov, Dimitry A., et al.
Publicado: (2014) -
Quantitative Assessment of Heteroplasmy of Mitochondrial Genome: Perspectives in Diagnostics and Methodological Pitfalls
por: Sobenin, Igor A., et al.
Publicado: (2014) -
Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects
por: Chistiakov, Dimitry A., et al.
Publicado: (2014)